A. O. Buijsse

Most-cited papers

1. Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo

   A. Labrijn, A. O. Buijsse, Ewald T. J. van den Bremer, A. Verwilligen +8 more

   2009Nature Biotechnology288 citations

   Semantic Scholar

   Save

2. Direct in Vitro Comparison of Daratumumab with Surrogate Analogs of CD38 Antibodies MOR03087, SAR650984 and Ab79

   J. L. V. van Bueren, D. Jakobs, N. Kaldenhoven, Marcel Roza +12 more

   2014206 citations

   Semantic Scholar

   Save

3. Supporting Online Material Materials and Methods Figs. S1 to S6 Table S1 References Functional Architecture and Evolution of Transcriptional Elements That Drive Gene Coexpression

   J. Schuurman, G. Perdok, A. Gorter, R. C. Aalberse +11 more

   131 citations

   Semantic Scholar

   Save

4. Abstract 2391: DR5 agonist activity of HexaBody®-DR5/DR5 (GEN1029) is potentiated by C1q and independent of Fc-gamma receptor binding in preclinical tumor models

   M. Overdijk, K. Strumane, A. O. Buijsse, C. Vermot-Desroches +11 more

   2019Immunology8 citations

   Semantic Scholar

   Save

5. C1q potentiates DR5 agonist activity by a mixture of two DR5-specific HexaBody® molecules

   F. Beurskens, M. Overdijk, K. Strumane, A. O. Buijsse +9 more

   2018Molecular Immunology0 citations

   Semantic Scholar

   Save

6. Abstract 592: Improving therapeutic activity of agonistic DR5 antibodies by inducing target binding-dependent hexamer formation

   M. Overdijk, K. Strumane, A. O. Buijsse, C. Vermot-Desroches +4 more

   20160 citations

   Semantic Scholar

   Save